Postimaging Colorectal Cancer After Computed Tomography Colonography: A Danish Nationwide Study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 41525170.
- Also identified by DOI 10.14309/ajg.0000000000003849.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Postimaging colorectal cancers (PICRCs) are defined by the World Endoscopy Organization as CRCs occurring more than 6 and up to 36 months after a negative colorectal imaging investigation (PICRC-3y). We calculated the absolute risk of PICRC among all participants who underwent computed tomography colonography (CTC) and estimated the proportion of all CRCs diagnosed after a CTC that could be classified as PICRC-3y. We performed a nationwide study within the entire Danish population covering the period 2010-2020 with 2 aims. First, we followed patients from 7 months after their first-time CTC until the first PICRC occurrence, death, colectomy, emigration, or 36 months, and calculated 7- to 36-month cumulative incidence proportions for PICRC, as a measure of absolute risk. Second, we calculated PICRC-3y-rates by dividing the number of false-negative CTCs by the total numbers of true-positive and false-negative CTCs. We identified 26,405 patients undergoing CTC, for whom the most likely indication (58%) was an incomplete colonoscopy within 3 months of the CTC. The 7- to 36-month cumulative incidence proportion for PICRC was 0.50% (95% confidence interval [CI]: 0.41%-0.61%) overall and 0.57% (95% CI: 0.44-0.72) for those with an incomplete colonoscopy. Based on 767 CTCs, the overall PICRC-3y-rate was 19% (95% CI: 16%-22%). The PICRC-3y-rate was 18% (95% CI: 15%-22%) for 491 (64%) cases with CTCs performed after an incomplete colonoscopy. We found a higher overall PICRC-3y-rate than previously reported. The overall PICRC-3y-rate was also higher than reported 3-year rates for postcolonoscopy CRCs.